RARX
AllianceBernstein’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-310,218
| Closed | -$14.9M | – | 3323 |
|
|
2020
Q1 | $14.9M | Sell |
310,218
-198,791
| -39% | -$9.54M | 0.01% | 778 |
|
|
2019
Q4 | $23.9M | Sell |
509,009
-265,636
| -34% | -$12.5M | 0.01% | 761 |
|
|
2019
Q3 | $18.3M | Buy |
774,645
+735,145
| +1,861% | +$17.4M | 0.01% | 821 |
|
|
2019
Q2 | $1.19M | Buy |
39,500
+12,900
| +48% | +$388K | ﹤0.01% | 2229 |
|
|
2019
Q1 | $596K | Buy |
26,600
+1,300
| +5% | +$29.1K | ﹤0.01% | 2453 |
|
|
2018
Q4 | $460K | Buy |
25,300
+7,900
| +45% | +$144K | ﹤0.01% | 2511 |
|
|
2018
Q3 | $315K | Buy |
17,400
+2,700
| +18% | +$48.9K | ﹤0.01% | 2815 |
|
|
2018
Q2 | $146K | Buy |
+14,700
| New | +$146K | ﹤0.01% | 3010 |
|
|
2017
Q3 | – | Sell |
-10,400
| Closed | -$195K | – | 3122 |
|
|
2017
Q2 | $195K | Buy |
+10,400
| New | +$195K | ﹤0.01% | 2977 |
|